<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39326914</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">1399-3003</ISSN><JournalIssue CitedMedium="Internet"><Volume>64</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Nov</Month></PubDate></JournalIssue><Title>The European respiratory journal</Title><ISOAbbreviation>Eur Respir J</ISOAbbreviation></Journal><ArticleTitle>Single-cell sequencing reveals cellular landscape alterations in the airway mucosa of patients with pulmonary long COVID.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2301947</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1183/13993003.01947-2023</ELocationID><Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">To elucidate the important cellular and molecular drivers of pulmonary long COVID, we generated a single-cell transcriptomic map of the airway mucosa using bronchial brushings from patients with long COVID who reported persistent pulmonary symptoms.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">Adults with and without long COVID were recruited from the general community in Greater Vancouver, Canada. The cohort was divided into those with pulmonary long COVID, which was defined as persons with new or worsening respiratory symptoms following &#x2265;12 weeks from their initial acute severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (n=9); and control subjects defined as SARS-CoV-2 infected persons whose acute respiratory symptoms had fully resolved or individuals who had no history of acute coronavirus disease 2019 (COVID-19) (n=9). These participants underwent bronchoscopy from which a single cell suspension was created from bronchial brush samples and then sequenced.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 56&#x2009;906 cells were recovered for the downstream analysis, with 34&#x2009;840 cells belonging to the pulmonary long COVID group, which strikingly showed a unique cluster of neutrophils in the pulmonary long COVID group (p&lt;0.05). Ingenuity Pathway Analysis revealed that the neutrophil degranulation pathway was enriched across epithelial cell clusters. Differential gene expression analysis between the pulmonary long COVID and control groups demonstrated upregulation of inflammatory chemokines and epithelial barrier dysfunction across epithelial cell clusters, as well as over-expression of mucin genes across secretory cell clusters.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">A single-cell transcriptomic landscape of the small airways suggest that neutrophils may play a significant role in mediating the chronic small airway inflammation driving pulmonary symptoms of long COVID.</AbstractText><CopyrightInformation>Copyright &#xa9;The authors 2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gerayeli</LastName><ForeName>Firoozeh V</ForeName><Initials>FV</Initials><AffiliationInfo><Affiliation>Centre for Heart Lung Innovation, St Paul's Hospital, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>F.V. Gerayeli and H.Y. Park contributed equally as co-first authors.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Hye Yun</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>Centre for Heart Lung Innovation, St Paul's Hospital, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>F.V. Gerayeli and H.Y. Park contributed equally as co-first authors.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Milne</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-5274-1298</Identifier><AffiliationInfo><Affiliation>Centre for Heart Lung Innovation, St Paul's Hospital, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine and Health, University of Sydney, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xuan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Centre for Heart Lung Innovation, St Paul's Hospital, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Chen Xi</ForeName><Initials>CX</Initials><Identifier Source="ORCID">0000-0002-8033-4769</Identifier><AffiliationInfo><Affiliation>Centre for Heart Lung Innovation, St Paul's Hospital, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tuong</LastName><ForeName>Josie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centre for Heart Lung Innovation, St Paul's Hospital, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eddy</LastName><ForeName>Rachel L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Centre for Heart Lung Innovation, St Paul's Hospital, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vahedi</LastName><ForeName>Seyed Milad</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Centre for Heart Lung Innovation, St Paul's Hospital, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guinto</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-4239-0006</Identifier><AffiliationInfo><Affiliation>Centre for Heart Lung Innovation, St Paul's Hospital, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheung</LastName><ForeName>Chung Y</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Centre for Heart Lung Innovation, St Paul's Hospital, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Julia S W</ForeName><Initials>JSW</Initials><AffiliationInfo><Affiliation>Centre for Heart Lung Innovation, St Paul's Hospital, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gilchrist</LastName><ForeName>Cassie</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Centre for Heart Lung Innovation, St Paul's Hospital, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yehia</LastName><ForeName>Dina</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Stach</LastName><ForeName>Tara</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Biomedical Research Centre, School of Biomedical Engineering, UBC, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dang</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>University of North Carolina Chapel Hill, Cystic Fibrosis and Pulmonary Disease Research and Treatment Center, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leung</LastName><ForeName>Clarus</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-3515-7537</Identifier><AffiliationInfo><Affiliation>Centre for Heart Lung Innovation, St Paul's Hospital, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaipanich</LastName><ForeName>Tawimas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leipsic</LastName><ForeName>Jonathon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Radiology, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koelwyn</LastName><ForeName>Graeme J</ForeName><Initials>GJ</Initials><AffiliationInfo><Affiliation>Centre for Heart Lung Innovation, St Paul's Hospital, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leung</LastName><ForeName>Janice M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Centre for Heart Lung Innovation, St Paul's Hospital, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sin</LastName><ForeName>Don D</ForeName><Initials>DD</Initials><AffiliationInfo><Affiliation>Centre for Heart Lung Innovation, St Paul's Hospital, Vancouver, BC, Canada Don.Sin@hli.ubc.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur Respir J</MedlineTA><NlmUniqueID>8803460</NlmUniqueID><ISSNLinking>0903-1936</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059010" MajorTopicYN="Y">Single-Cell Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020545" MajorTopicYN="Y">Respiratory Mucosa</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001999" MajorTopicYN="N">Bronchoscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009504" MajorTopicYN="N">Neutrophils</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Conflict of interest: F.V. Geraveli reports grants from MiTACS Accelerate. S. Milne reports payment or honoraria for lectures, presentations, manuscript writing or educational events from Chiesi Australia, The Limbic Australia and Research Review Australia, support for attending meetings from Sanofi Australia, Chiesi Australia and AstraZeneca, and a leadership role with Thoracic Society of Australia and New Zealand (NSW/ACT). R.L. Eddy reports grants from Michael Smith Health Research BC, Canadian Respiratory Research Network and Natural Sciences and Engineering Research Council Canada, consultancy fees from VIDA Diagnostics Inc., payment or honoraria for lectures, presentations, manuscript writing or educational events from Thorasys Thoracic Medical Systems Inc., and support for attending meetings from Canadian Institutes of Health Research &#x2013; Institute of Circulatory and Respiratory Health. C. Gilchrist reports grants from Canadian institutes of Health Research. J. Leipsic reports consultancy fees from Heartflow, and stock (or stock options) with Heartflow. J.M. Leung reports support for the present study from Canadian Institutes of Health Research, grants from Canadian Institutes of Health Research and BC Lung Foundation, payment or honoraria for lectures, presentations, manuscript writing or educational events from BC Lung Foundation and University of British Columbia, participation on a data safety monitoring board with Enhance Quality Safety and Patient experience in Chronic Obstructive Pulmonary Disorder (EQuiP COPD), and leadership roles with Canadian Respiratory Research Network and the CanCOLD Study. D.D. Sin reports payment or honoraria for lectures, presentations, manuscript writing or educational events from GSK, AstraZeneca and Boehringer Ingelheim, and participation on a data safety monitoring board or advisory board with NHLBI. The remaining authors have no potential conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>29</Day><Hour>5</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>26</Day><Hour>20</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39326914</ArticleId><ArticleId IdType="doi">10.1183/13993003.01947-2023</ArticleId><ArticleId IdType="pii">13993003.01947-2023</ArticleId><ArticleId IdType="pmc">PMC11602667</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization (WHO) . WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int/. Date last accessed: 1 November 2023.</Citation></Reference><Reference><Citation>Greenhalgh T, Knight M, A'Court C, et al. . Management of post-acute covid-19 in primary care. BMJ 2020; 370: m3026. doi:10.1136/bmj.m3026</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol 2021; 12: 698169. doi:10.3389/fmicb.2021.698169</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, et al. . Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 2023; 21: 133&#x2013;146. doi:10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al. . Characterizing long COVID in an international cohort: 7&#x2005;months of symptoms and their impact. EClinicalMedicine 2021; 38: 101019. doi:10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentilotti E, G&#xf3;rska A, Tami A, et al. . Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort. EClinicalMedicine 2023; 62: 102107. doi:10.1016/j.eclinm.2023.102107</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.102107</ArticleId><ArticleId IdType="pmc">PMC10466236</ArticleId><ArticleId IdType="pubmed">37654668</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodruff MC, Bonham KS, Anam FA, et al. . Chronic inflammation, neutrophil activity, and autoreactivity splits long COVID. Nat Commun 2023; 14: 4201. doi:10.1038/s41467-023-40012-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-40012-7</ArticleId><ArticleId IdType="pmc">PMC10349085</ArticleId><ArticleId IdType="pubmed">37452024</ArticleId></ArticleIdList></Reference><Reference><Citation>Government of Canada . COVID-19: Longer-Term Symptoms Among Canadian Adults &#x2013; Highlights. https://health-infobase.canada.ca/covid-19/post-covid-condition/. Date last accessed: 1 November 2023.</Citation></Reference><Reference><Citation>Milne S, Li X, Yang CX, et al. . Inhaled corticosteroids downregulate SARS-CoV-2-related genes in COPD: results from a randomised controlled trial. Eur Respir J 2021; 58: 2100130. doi:10.1183/13993003.00130-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00130-2021</ArticleId><ArticleId IdType="pmc">PMC8015643</ArticleId><ArticleId IdType="pubmed">33795322</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerayeli FV, Eddy R, Sin DD. A proposed approach to pulmonary long COVID: a viewpoint. Eur Respir J 2024; 64: 2302302. doi:10.1183/13993003.02302-2023</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02302-2023</ArticleId><ArticleId IdType="pmc">PMC11391093</ArticleId><ArticleId IdType="pubmed">38453258</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerayeli FV, Milne S, Yang CX, et al. . Single-cell RNA sequencing of bronchoscopy specimens: development of a rapid minimal handling protocol. Biotechniques 2023; 75: 157&#x2013;167. doi:10.2144/btn-2023-0017</Citation><ArticleIdList><ArticleId IdType="doi">10.2144/btn-2023-0017</ArticleId><ArticleId IdType="pubmed">37815826</ArticleId></ArticleIdList></Reference><Reference><Citation>10X Genomics . Chromium Single Cell 3' Reagent Kits User Guide (v3.1 Chemistry). 2019. https://cdn.10xgenomics.com/image/upload/v1660261285/support-documents/CG000204_ChromiumNextGEMSingleCell3_v3.1_Rev_D.pdf.</Citation></Reference><Reference><Citation>Young MD, Behjati S. SoupX removes ambient RNA contamination from droplet-based single-cell RNA sequencing data. Gigascience 2020; 9: giaa151. doi:10.1093/gigascience/giaa151</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gigascience/giaa151</ArticleId><ArticleId IdType="pmc">PMC7763177</ArticleId><ArticleId IdType="pubmed">33367645</ArticleId></ArticleIdList></Reference><Reference><Citation>Traag VA, Waltman L, van Eck NJ. From Louvain to Leiden: guaranteeing well-connected communities. Sci Rep 2019; 9: 5233. doi:10.1038/s41598-019-41695-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-41695-z</ArticleId><ArticleId IdType="pmc">PMC6435756</ArticleId><ArticleId IdType="pubmed">30914743</ArticleId></ArticleIdList></Reference><Reference><Citation>Franz&#xe9;n O, Gan LM, Bj&#xf6;rkegren JLM. PanglaoDB: a web server for exploration of mouse and human single-cell RNA sequencing data. Database 2019; 2019: baz046. doi:10.1093/database/baz046</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/database/baz046</ArticleId><ArticleId IdType="pmc">PMC6450036</ArticleId><ArticleId IdType="pubmed">30951143</ArticleId></ArticleIdList></Reference><Reference><Citation>Hewitt RJ, Lloyd CM. Regulation of immune responses by the airway epithelial cell landscape. Nat Rev Immunol 2021; 21: 347&#x2013;362. doi:10.1038/s41577-020-00477-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-00477-9</ArticleId><ArticleId IdType="pmc">PMC7804588</ArticleId><ArticleId IdType="pubmed">33442032</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaragosi LE, Deprez M, Barbry P. Using single-cell RNA sequencing to unravel cell lineage relationships in the respiratory tract. Biochem Soc Trans 2020; 48: 327&#x2013;336. doi:10.1042/BST20191010</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST20191010</ArticleId><ArticleId IdType="pubmed">31922198</ArticleId></ArticleIdList></Reference><Reference><Citation>Okuda K, Chen G, Subramani D, et al. Localization of secretory mucins MUC5AC and MUC5B in normal/healthy human airways. Am J Respir Crit Care Med 2019; 199: 715&#x2013;727. doi:10.1164/rccm.201804-0734OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201804-0734OC</ArticleId><ArticleId IdType="pmc">PMC6423099</ArticleId><ArticleId IdType="pubmed">30352166</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis JD, Wypych TP. Cellular and functional heterogeneity of the airway epithelium. Mucosal Immunol 2021; 14: 978&#x2013;990. doi:10.1038/s41385-020-00370-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41385-020-00370-7</ArticleId><ArticleId IdType="pmc">PMC7893625</ArticleId><ArticleId IdType="pubmed">33608655</ArticleId></ArticleIdList></Reference><Reference><Citation>He L, Davila-Velderrain J, Sumida TS, et al. . NEBULA is a fast negative binomial mixed model for differential or co-expression analysis of large-scale multi-subject single-cell data. Commun Biol 2021; 4: 629. doi:10.1038/s42003-021-02146-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-02146-6</ArticleId><ArticleId IdType="pmc">PMC8155058</ArticleId><ArticleId IdType="pubmed">34040149</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R, Sang L, Jiang M, et al. . Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China. J Allergy Clin Immunol 2020; 146: 89&#x2013;100. doi:10.1016/j.jaci.2020.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.05.003</ArticleId><ArticleId IdType="pmc">PMC7212968</ArticleId><ArticleId IdType="pubmed">32407836</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiang CC, Korinek M, Cheng WJ, et al. . Targeting neutrophils to treat acute respiratory distress syndrome in coronavirus disease. Front Pharmacol 2020; 11: 572009. doi:10.3389/fphar.2020.572009</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.572009</ArticleId><ArticleId IdType="pmc">PMC7583590</ArticleId><ArticleId IdType="pubmed">33162887</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilk AJ, Rustagi A, Zhao NQ, et al. . A single-cell atlas of the peripheral immune response in patients with severe COVID-19. Nat Med 2020; 26: 1070&#x2013;1076. doi:10.1038/s41591-020-0944-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0944-y</ArticleId><ArticleId IdType="pmc">PMC7382903</ArticleId><ArticleId IdType="pubmed">32514174</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulte-Schrepping J, Reusch N, Paclik D, et al. . Severe COVID-19 is marked by a dysregulated myeloid cell compartment. Cell 2020; 182: 1419&#x2013;1440. doi:10.1016/j.cell.2020.08.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.001</ArticleId><ArticleId IdType="pmc">PMC7405822</ArticleId><ArticleId IdType="pubmed">32810438</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Zhang K, Zhang Y, et al. . Neutrophils in COVID-19: recent insights and advances. Virol J 2023; 20: 169. doi:10.1186/s12985-023-02116-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-023-02116-w</ArticleId><ArticleId IdType="pmc">PMC10398943</ArticleId><ArticleId IdType="pubmed">37533131</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Z, Ren L, Zhang L, et al. . Heightened innate immune responses in the respiratory tract of COVID-19 patients. Cell Host Microbe 2020; 27: 883&#x2013;890. doi:10.1016/j.chom.2020.04.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.04.017</ArticleId><ArticleId IdType="pmc">PMC7196896</ArticleId><ArticleId IdType="pubmed">32407669</ArticleId></ArticleIdList></Reference><Reference><Citation>George PM, Reed A, Desai SR, et al. . A persistent neutrophil-associated immune signature characterizes post-COVID-19 pulmonary sequelae. Sci Transl Med 2022; 14: eabo5795. doi:10.1126/scitranslmed.abo5795</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abo5795</ArticleId><ArticleId IdType="pubmed">36383686</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Zhou Z, Min W. Mitochondria, oxidative stress and innate immunity. Front Physiol 2018; 9: 1487. doi:10.3389/fphys.2018.01487</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2018.01487</ArticleId><ArticleId IdType="pmc">PMC6200916</ArticleId><ArticleId IdType="pubmed">30405440</ArticleId></ArticleIdList></Reference><Reference><Citation>Dipankar P, Kumar P, Dash SP, et al. . Functional and therapeutic relevance of Rho GTPases in innate immune cell migration and function during inflammation: an in silico perspective. Mediators Inflamm 2021; 2021: 6655412. doi:10.1155/2021/6655412</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/6655412</ArticleId><ArticleId IdType="pmc">PMC7896857</ArticleId><ArticleId IdType="pubmed">33628114</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeilhofer HU, Schorr W. Role of interleukin-8 in neutrophil signaling. Curr Opin Hematol 2000; 7: 178&#x2013;182. doi:10.1097/00062752-200005000-00009</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00062752-200005000-00009</ArticleId><ArticleId IdType="pubmed">10786656</ArticleId></ArticleIdList></Reference><Reference><Citation>Proost P, De Wolf-Peeters C, Conings R, et al. . Identification of a novel granulocyte chemotactic protein (GCP-2) from human tumor cells. In vitro and in vivo comparison with natural forms of GRO, IP-10, and IL-8. J Immunol 1993; 150: 1000&#x2013;1010. doi:10.4049/jimmunol.150.3.1000</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.150.3.1000</ArticleId><ArticleId IdType="pubmed">8423327</ArticleId></ArticleIdList></Reference><Reference><Citation>Nugteren S, Samsom JN. Secretory leukocyte protease inhibitor (SLPI) in mucosal tissues: protects against inflammation, but promotes cancer. Cytokine Growth Factor Rev 2021; 59: 22&#x2013;35. doi:10.1016/j.cytogfr.2021.01.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2021.01.005</ArticleId><ArticleId IdType="pubmed">33602652</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao MX, Nadel JA. Neutrophil elastase induces MUC5AC mucin production in human airway epithelial cells via a cascade involving protein kinase C, reactive oxygen species, and TNF-&#x3b1;-converting enzyme. J Immunol 2005; 175: 4009&#x2013;4016. doi:10.4049/jimmunol.175.6.4009</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.175.6.4009</ArticleId><ArticleId IdType="pubmed">16148149</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer BM, Voynow JA. Neutrophil elastase induces MUC5AC gene expression in airway epithelium via a pathway involving reactive oxygen species. Am J Respir Cell Mol Biol 2002; 26: 447&#x2013;452. doi:10.1165/ajrcmb.26.4.4473</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/ajrcmb.26.4.4473</ArticleId><ArticleId IdType="pubmed">11919081</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol 2022; 23: 194&#x2013;202. doi:10.1038/s41590-021-01104-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J, Xiao J, Sun R, et al. . Prolonged persistence of SARS-CoV-2 RNA in body fluids. Emerg Infect Dis 2020; 26: 1834&#x2013;1838. doi:10.3201/eid2608.201097</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2608.201097</ArticleId><ArticleId IdType="pmc">PMC7392422</ArticleId><ArticleId IdType="pubmed">32383638</ArticleId></ArticleIdList></Reference><Reference><Citation>Leiva-Ju&#xe1;rez MM, Kolls JK, Evans SE. Lung epithelial cells: therapeutically inducible effectors of antimicrobial defense. Mucosal Immunol 2018; 11: 21&#x2013;34. doi:10.1038/mi.2017.71</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mi.2017.71</ArticleId><ArticleId IdType="pmc">PMC5738267</ArticleId><ArticleId IdType="pubmed">28812547</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlier FM, de Fays C, Pilette C. Epithelial barrier dysfunction in chronic respiratory diseases. Front Physiol 2021; 12: 691227. doi:10.3389/fphys.2021.691227</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2021.691227</ArticleId><ArticleId IdType="pmc">PMC8264588</ArticleId><ArticleId IdType="pubmed">34248677</ArticleId></ArticleIdList></Reference><Reference><Citation>Michalick L, Kuebler WM. TRPV4 &#x2013; a missing link between mechanosensation and immunity. Front Immunol 2020; 11: 413. doi:10.3389/fimmu.2020.00413</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00413</ArticleId><ArticleId IdType="pmc">PMC7076180</ArticleId><ArticleId IdType="pubmed">32210976</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>